AXSOME THERAPEUTICS INC. - COMMON STOCK

Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Hikma Pharmaceuticals USA

05 3月 2025 06:00:00 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-05 in Alzheimer’s Disease Agitation Supporting NDA Submission

03 3月 2025 06:00:00 条件 Nasdaq GlobeNewswire

Axsome Therapeutics to Participate in Upcoming Investor Conferences

26 2月 2025 06:00:00 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the EMERGE Phase 3 Trial in Migraine Patients Experiencing Inadequate Response to Oral CGRP Inhibitors

24 2月 2025 06:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

21 2月 2025 10:16:01 条件 NetDania Notify

Axsome Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

18 2月 2025 06:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

11 2月 2025 09:02:00 条件 NetDania Notify

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

10 2月 2025 08:45:13 条件 NetDania Notify

Axsome Therapeutics Announces Settlement Agreement Resolving AUVELITY® (dextromethorphan HBr – bupropion HCl) Patent Litigation

10 2月 2025 06:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

06 2月 2025 08:55:37 条件 NetDania Notify

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

05 2月 2025 08:45:07 条件 NetDania Notify

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

04 2月 2025 09:19:52 条件 NetDania Notify

Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader

31 1月 2025 06:00:00 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Announces FDA Approval of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults

30 1月 2025 14:45:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

30 1月 2025 08:45:15 条件 NetDania Notify

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

27 1月 2025 09:08:34 条件 NetDania Notify

Axsome Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18

22 1月 2025 06:00:00 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue

13 1月 2025 06:00:01 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Announces Successful Completion and Results of Phase 3 Clinical Program of AXS-05 in Alzheimer’s Disease Agitation

30 12月 2024 06:00:00 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in ENCORE Long-Term Phase 3 Trial in Narcolepsy

26 11月 2024 06:00:00 条件 Nasdaq GlobeNewswire